These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 32816)

  • 1. [Spectrofluorimetric estimation in biological fluids of a new beta-blockader: atenolol. Application to its pharmacokinetic study (author's transl)].
    Flouvat B; Bazin M; Lucsko M; Roux A; Guedon J
    Ann Biol Clin (Paris); 1978; 36(4):339-46. PubMed ID: 32816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spectrofluorometric determination of a new beta-blocking agent, acebutolol in blood and urine].
    Roux A; Flouvat B; Delaveau P
    Ann Biol Clin (Paris); 1975; 33(4):281-8. PubMed ID: 2088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of atenolol in man.
    Reeves PR; McAinsh J; McIntosh DA; Winrow MJ
    Xenobiotica; 1978 May; 8(5):313-20. PubMed ID: 27019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination in biologic media of a new beta-blocker, atenolol, by high performance liquid chromatography].
    Decourt S; Flouvat B
    J Chromatogr; 1979 Jun; 174(1):258-63. PubMed ID: 546890
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prolonged hypotension after the first dose of atenolol (author's transl)].
    Montoliu J; Botey A; Darnell A; Revert L
    Med Clin (Barc); 1981 Apr; 76(8):365-6. PubMed ID: 7253756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and quantitation of (R)- and (S)-atenolol in human plasma and urine using an alpha 1-AGP column.
    Enquist M; Hermansson J
    Chirality; 1989; 1(3):209-15. PubMed ID: 2642050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
    Rengo F; Trimarco B; Petretta M; Ferrara N; Bonaduce D; Chiariello M; Condorelli M
    G Ital Cardiol; 1978; 8(8):861-7. PubMed ID: 359398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
    Saghir SA; Clark AJ; McClymont EL; Staley JL
    Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man.
    Houin G; Barre J; Jeanniot JP; Ledudal P; Cautreels W; Tillement JP
    Int J Clin Pharmacol Res; 1984; 4(3):175-83. PubMed ID: 6149195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
    Mierau J
    Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of pindolol in a group of elderly hypertensive patients (author's transl)].
    Salathé B; Kerle FH
    Aktuelle Gerontol; 1980 Oct; 10(10):443-7. PubMed ID: 6110350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
    Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
    Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V; Antonacci A; Prandi P; Bokor D; Pirrelli A
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorimetric determination of atenolol in plasma and urine by direct evaluation of thin-layer chromatograms.
    Schäfer M; Mutschler E
    J Chromatogr; 1979 Feb; 169():477-81. PubMed ID: 536437
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics of isosorbide dinitrate administered by intravenous infusion to hypertensive patients (author's transl)].
    Frydman A; Levenson J; Simon A; Safar M; Bieder A; Bertharion J; Gaillot J
    Nouv Presse Med; 1982 Jun; 11(27):2049-56. PubMed ID: 7110964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation by exercise test of effects of a single oral dose of atenolol in patients with stable angina (author's transl)].
    de Divitiis O; de Simone G; Maddalena G; Castaldo M; Ruggiano A
    G Ital Cardiol; 1981; 11(12):2088-96. PubMed ID: 7049818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.